The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.30
Bid: 94.80
Ask: 95.10
Change: 1.70 (1.84%)
Spread: 0.30 (0.316%)
Open: 91.80
High: 95.20
Low: 91.80
Prev. Close: 92.60
HTWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

30 Nov 2022 07:00

RNS Number : 9800H
Helios Towers PLC
30 November 2022
 

30 November 2022

 

Helios Towers plc

 

Total Voting Rights Announcement

 

In conformity with the DTR5.6.1, Helios Towers plc (the "Company") announces the following:

 

As at the date of this announcement, the Company's issued ordinary share capital consists of 1,050,500,000 ordinary shares of £0.01 each, all with voting rights. The Company holds no ordinary shares in treasury.

 

The total number of voting rights in the Company is therefore 1,050,500,000.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

LEI: 213800DGC7GS4XCHCU30

Identification Code: GB00BJVQC708

 

 

Enquires:

 

For investor enquiries:

investorrelations@heliostowers.com

For media enquires:

Edward Bridges, Stephanie Ellis

FTI Consulting LLP

+44 (0)20 3727 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBLBDBLXDDGDC
Date   Source Headline
25th Apr 20243:40 pmRNS2024 Annual General Meeting Results
23rd Apr 20247:00 amRNSNotice of Q1 2024 Results Date & Conference Call
22nd Apr 20247:00 amRNSCredit rating upgrade
16th Apr 20242:29 pmRNSDirector/PDMR Shareholding
28th Mar 20248:57 amRNSTotal Voting Rights
25th Mar 202410:31 amRNSDoc re Annual Report and Financial Statements
20th Mar 202412:31 pmRNSDirector/PDMR Shareholding
19th Mar 20242:52 pmRNSHolding(s) in Company
19th Mar 20247:56 amRNSHolding(s) in Company
15th Mar 202412:52 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSResults for the year and quarter ended 31 Dec 2023
26th Jan 20249:00 amRNSDirectorate Change
18th Jan 20247:00 amRNSNotice of FY 2023 Results Date & Conference Call
3rd Nov 20237:05 amRNSBlock Listing Interim Review
2nd Nov 20237:00 amRNSQ3 2023 Results
16th Oct 20237:01 amRNSResults of capped tender offer
16th Oct 20237:00 amRNSResults of Tender Offer for Senior Notes
10th Oct 20237:00 amRNSNotice of Q3 2023 Results Date & Conference Call
3rd Oct 20231:29 pmRNSDirector/PDMR Shareholding
28th Sep 20231:34 pmRNSExtension of Early Tender Time
14th Sep 20237:05 amRNSNew Facilities and tender offer of Senior Notes
14th Sep 20237:00 amRNSUp to $400m Tender Offer for Senior Notes
3rd Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSNotice of H1 2023 Results Date & Conference Call
23rd May 20231:39 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirectorate Change
18th May 20237:00 amRNSQ1 2023 Results
3rd May 202311:25 amRNSBlock Listing Interim Review
27th Apr 20233:39 pmRNS2023 Annual General Meeting Results
17th Apr 20239:44 amRNSNotice of Q1 2023 Results Date & Conference Call
27th Mar 20232:16 pmRNS2022 Annual Report and 2023 Notice of AGM
16th Mar 20237:00 amRNSFinal Results
27th Jan 20237:00 amRNSNotice of FY2022 Results Date & Conference Call
15th Dec 20225:56 pmRNSHolding in Company
8th Dec 20222:55 pmRNSClosing of tower acquisition in Oman
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSUpdate on Omantel Tower Portfolio Acquisition
14th Nov 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
9th Nov 20228:53 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSQ3 2022 Results
6th Oct 20227:00 amRNSNotice of Q3 2022 Results Date & Conference Call
3rd Oct 20227:00 amRNSBlock Listing Application
29th Sep 202212:03 pmRNSOmantel Tower Acquisition Long-Stop Date Extension
18th Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSHalf-year Report
13th Jul 20227:00 amRNSNotice of H1 2022 Results Date & Conference Call
5th Jul 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
21st Jun 202212:49 pmRNSDirector/PDMR Shareholding
17th Jun 202210:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.